Assessing LNP Immunogenicity & Toxicity to Effectively Monitor Clinical Safety & Ensure Regulatory Compliance for Novel Therapeutics & Vaccines
Achieve Superior LNP Patient Safety Profiles for Your Cargo at the 4th LNP Immunogenicity & Toxicity Digital Summit
Recent success of LNP safety has put the industry back in the spotlight. From personalized CRISPR treatments and Capstan’s phase I trial initiation for autoimmune diseases, to Verve’s recent clinical progress to lower cholesterol; these headlines have reignited the hope for LNPs to solve the biggest hurdles in drug delivery.
The 4th LNP Immunogenicity & Toxicity returns in December, as an industry-dedicated virtual forum, bringing you the key updates on pre-clinical and clinical safety assessments and assays to effectively measure and monitor LNP safety for gene and cell therapies and vaccine applications.
This year’s exclusive one-day program will provide you with an entire day of scientific progress and technical insights into LNP mechanism of action, translational animal model approaches, and pharmacokinetic and dynamic studies to support the prediction, dosing strategy, and improve clinical effectiveness of pegylated and ionizable LNPs across all payloads.
Log on to the platform from the comfort or your home or office and connect with 80+ fellow LNP experts spanning non-clinical and clinical safety, from immunology, toxicology, pharmacology, and bioanalytics to learn, share, and network virtually to support the development of safer LNPs for patients faster.
Official Agenda
World-Class Speaker Faculty Includes:
Previously Attending Companies Include:
An Insightful Day “Out of Office”
- 80+ LNP Experts
- 10+ Speakers
- 3 Hours of Networking
- and more...
What Your Peers Have to Say:
"This conference brought together experts in the LNP space to address the safety of LNPs - particularly as it relates to anti-PEG antibodies. The best conference I have ever attended!"'
"An interactive and informative conference where people in the field share knowledge and challenges to be overcome."
Other Events in the LNP Development Series:
